newsfilter
← Latest News
GlobeNewswire·

CohBar Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update

MENLO PARK, Calif., March 29, 2022 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ:CWBR), a clinical stage biotechnology company leveraging the power of the mitochondria and the peptides encoded in its genome to develop potential breakthrough therapeutics tar